Nalmefen-Hydrochlorid-Dihydrat

European patent · EP2441766 · In force

Register entry

Publication number
EP2441766
Application number
EP12150266
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 4, 2009
Published
Apr 18, 2012
Granted
Jun 25, 2014
Protection ends at the latest
Dec 3, 2029
Next annual fee due
Dec 31, 2026
IPC classes
C07D 489/08 (2006.01)
A61K 31/485 (2006.01)
A61P 25/30 (2006.01)
Priority
DK 200801729 05.12.2008
US 120132 P 05.12.2008
Divided from
EP09771286
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Jun 25, 2014

    Granted

    Published in Swissreg on 25.06.2014

Parties

Holder

H. Lundbeck A/S

Ottiliavej 9, 2500 Valby-Copenhagen, DK

Biotie Therapies Corp.

Tykistökatu 6, 20520 Turku, FI

Inventor

Lopez de Diego, Heidi

2850 Närum, DK

De Faveri, Carla

31010 Farra di Soligo, IT

Huber, Florian Anton Martin

36050 Bolzano Vicentino, IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.